How does it work?
The most cited studies describe how Epitalon in cell models may affect telomerase-related markers and telomere length. The hypothesis in parts of the literature is that small regulatory peptides may influence the transcription of particular genes. This is mechanistic laboratory research, not documentation of clinical effect in humans.
Technical mechanism
Synthetic tetrapeptide. Research refers particularly to telomerase activity, gene expression and cellular ageing, but the body of data is small and heavily preclinical.
What is being researched?
- Telomerase activity and telomere length in human cell cultures
- Proliferation and division limit in somatic cells
- Hypotheses about gene regulation through short peptides
- Ageing-related mechanisms in preclinical models
About the evidence: The Epitalon page should be read as a cautious literature overview. There are PubMed-indexed studies and a recent review, but large, modern, independent clinical studies in humans are lacking.
Research profile
Studies and sources
The links go to independent research databases (PubMed, PubMed Central, ClinicalTrials.gov). The studies are in English and open in a new tab.
Telomerase and cellular ageing
The most relevant studies are cell experiments investigating telomerase activity and capacity for division.
- Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells PreclinicalPubMed· 2003
This laboratory study reported that Epithalon in human foetal fibroblasts could be linked to expression of the telomerase component, enzyme activity and telomere elongation. These are cell culture data and say nothing about documented effect in humans.
- Peptide promotes overcoming of the division limit in human somatic cell PreclinicalPubMed· 2004
The researchers investigated whether Epithalon could affect proliferative capacity in human fibroblasts. The work builds on earlier cell findings on telomerase, but is still laboratory research with no direct clinical transferability.
- Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties ReviewPubMed· 2025
This review examines naming, biological hypotheses and earlier in vitro, animal and human data for Epitalon. The review does not replace large independent clinical studies.